SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CAEA03FB3B483B9031BAEE61BF68BA071A88187A4683075DE9758E384D26233611516A883181EE487B79B3478A985CE4>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CAEA03FB3B483B9031BAEE61BF68BA071A88187A4683075DE9758E384D26233611516A883181EE487B79B3478A985CE4
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CAEA03FB3B483B9031BAEE61BF68BA071A88187A4683075DE9758E384D26233611516A883181EE487B79B3478A985CE4
http://www.w3.org/2000/01/rdf-schema#comment
"High CD31 expression associated significantly with better survival and VEGFR3 had no association with survival. Both higher tumor grade and stage were associated with a decreased survival time"
xsd:string
http://purl.uniprot.org/uniprot/#_3258784B3E5F7DC834C0A031D337DD19AB1A82464CAA173B7E86F5E8FCB0241943FA938BF5A1F6C46129F38092C50C74
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CAEA03FB3B483B9031BAEE61BF68BA071A88187A4683075DE9758E384D26233611516A883181EE487B79B3478A985CE4
http://purl.uniprot.org/uniprot/P35916
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CAEA03FB3B483B9031BAEE61BF68BA071A88187A4683075DE9758E384D26233611516A883181EE487B79B3478A985CE4
http://purl.uniprot.org/uniprot/#_P35916-mappedCitation-25667475
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CAEA03FB3B483B9031BAEE61BF68BA071A88187A4683075DE9758E384D26233611516A883181EE487B79B3478A985CE4